SCHEMBL3339428

SCHEMBL3339428

CCOC(=O)CC(=O)CCO[Si](C(C)C)(C(C)C)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.45
MGAM O43451 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.35
TRPA1 O75762 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
FAAH O00519 1/20 0.33
PKM P14618 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343220 0.83 GAA (0.48) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL4409901 0.77 GAA (0.50) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL22089529 0.75 GAA (0.44) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL563195 0.74 GAA (0.56) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL1127304 0.74 GAA (0.56) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL2074701 0.73 GAA (0.54) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL10048124 0.73 GAA (0.54) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL2262832 0.73 GAA (0.54) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL1224654 0.72 GAA (0.64) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL2593140 0.72 GAA (0.64) GAAMGAMSIMGAM2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof KIF5A, KIF5C, KIF5B GAA 590/4885MGAM 3539/4885SI 3453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.